| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT07518173 A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-26 | NCT07606599 A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06957886 | A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With… | HER2-low Breast Cancer | Recruiting |
| NCT06830889 | A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer… | HER2-positive Breast Cancer | Recruiting |
| NCT07518173 | A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and… | HER2-positive Breast Cancer | Recruiting |
| NCT07545460 | A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With… | Epithelial Ovarian Cancer | Not Yet Recruiting |
| NCT07606599 | A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With… | Biliary Tract Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT07264816 | A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable… | Non-squamous Non-small Cell Lung Cancer | Recruiting |
| NCT06445400 | A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients… | HER2-positive Breast Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06031584 | A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced… | Her2-positive/Low-expression Urinary and Digestive Tract Tumors | Recruiting |
| Phase 1 | |||
| NCT06293898 | Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors | Endometrial Cancer | Recruiting |